QY Research has published the new industry research of the “Global Acne Vulgaris Treatment Market Size and Forecast 2025” The report focuses on Global major leading players with information such as company profiles, product picture, future road map, opportunities and investment.
City of industry, CA -- (SBWIRE) -- 06/19/2018 -- This report studies the global Acne Vulgaris Treatment market status and forecast, categorizes the global Acne Vulgaris Treatment market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
The global Acne Vulgaris Treatment market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major manufacturers covered in this report
Common Pharma Inc
Cutanea Life Sciences Inc
Dermira Inc
ELORAC Inc
Ensol Biosciences Inc
Foamix Pharmaceuticals Ltd
Galderma SA
GlaxoSmithKline Plc
Helix BioMedix Inc
Hovione FarmaCiencia SA
Lee's Pharmaceutical Holdings Ltd
LEO Pharma A/S
Novabiotics Ltd
Novan Inc
Novartis AG
Paratek Pharmaceuticals Inc
Pfizer Inc
Phosphagenics Ltd
Request Sample Copy of the Report @ https://www.qyresearch.com/sample-form/form/247404/global-acne-vulgaris-treatment-market
QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert's resources (included energy automotive chemical medical ICT consumer goods etc.